Clinical Report: Spinal Ependymomas in Pediatric Patients

Background

Spinal ependymomas are rare tumors in the pediatric population, representing only 1% of childhood CNS neoplasms. In adults, they are the most common intramedullary spinal cord lesions. Understanding their classification and treatment is crucial for improving patient outcomes.

Data Highlights

Key Findings

• Spinal ependymomas are classified into four entities: SP-EPN, SP-EPN-MYCN, SP-SE, and SP-MPE.
• Gross total resection (GTR) is associated with improved progression-free and overall survival rates.
• Adjuvant radiotherapy is recommended for higher-grade spinal ependymomas when complete resection is not possible.
• MYCN amplification in SP-EPN-MYCN is linked to aggressive disease and early relapse.
• Pediatric SP-MPE cases show a significant difference in progression-free survival between methylation subtypes B and A, although not statistically significant.

Clinical Implications

Surgical resection remains the cornerstone of treatment for spinal ependymomas, with the extent of resection being a key determinant of outcomes.

Conclusion

The management of spinal ependymomas in pediatric patients requires a comprehensive approach that includes surgical intervention.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Author(s)/Org, Source, Year -- Title
5. ASCO Publications — Molecular Staging of Intracranial Ependymoma in Children and Adults
6. Solid Tumor Rules 2026 Update
7. Phase 3 randomized trial of postirradiation chemotherapy in patients with newly diagnosed ependymoma: A report from the Children’s Oncology Group | Neuro-Oncology | Oxford Academic
8. Pediatric spinal ependymomas: Long‐term surgical outcomes in a cohort of 61 cases - PMC